We conducted multi‐omics profiling, including whole exome sequencing (WES), RNA sequencing (RNA‐seq), proteome, and phosphoproteome analyses, on paired tumor and NAT samples from 144 Chinese CRC patients at Changzheng Hospital (Shanghai, China) (Figure 1A; Figure S1A; Table S1). Here, BRD2 is linked to neoplasm.